Psyence and Filament Health Enter Into Exclusive Licensing Agreements For Natural Psilocybin Products
Filament Health (FH) granted Psyence Group (PSYG) an exclusive license to use its natural psilocybin formulation in an upcoming palliative care trial in the UK. Filament recently received a patent for its technology for extracting and standardizing natural psilocybin.